cgp 12177 has been researched along with Thyroid Neoplasms in 1 studies
CGP 12177 : A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group.
Thyroid Neoplasms: Tumors or cancer of the THYROID GLAND.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohta, K | 1 |
| Pang, XP | 1 |
| Berg, L | 1 |
| Hershman, JM | 1 |
1 other study available for cgp 12177 and Thyroid Neoplasms
| Article | Year |
|---|---|
Growth inhibition of new human thyroid carcinoma cell lines by activation of adenylate cyclase through the beta-adrenergic receptor.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adult; Animals; Cell Division; Colforsin; Cyclic AMP; D | 1997 |